{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T13:27:49Z","timestamp":1679232469838},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T00:00:00Z","timestamp":1427760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12882-015-0030-8","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T22:04:41Z","timestamp":1427753081000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Wendy L","family":"St. Peter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akeem A","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thy","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly M","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan J","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,31]]},"reference":[{"key":"30_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350:1516\u201325.","journal-title":"N Engl J Med"},{"key":"30_CR2","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","volume":"20","author":"SM Moe","year":"2005","unstructured":"Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, et al. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant. 2005;20:2186\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"30_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1681\/ASN.2004060512","volume":"16","author":"JS Lindberg","year":"2005","unstructured":"Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol. 2005;16:800\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"30_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2215\/CJN.05241008","volume":"4","author":"WL St Peter","year":"2009","unstructured":"St Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, et al. Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006. Clin J Am Soc Nephrol. 2009;4:354\u201360.","journal-title":"Clin J Am Soc Nephrol"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2215\/CJN.01060308","volume":"3","author":"MD Danese","year":"2008","unstructured":"Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:1423\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"30_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70:771\u201380.","journal-title":"Kidney Int"},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10:98\u2013109.","journal-title":"Clin J Am Soc Nephrol"},{"key":"30_CR8","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.04260413","volume":"8","author":"GA Block","year":"2013","unstructured":"Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol. 2013;8:2132\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"key":"30_CR9","unstructured":"Department of Health and Human Services, Centers for Medicare and Medicaid: Federal Register. Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule - 42 CFR Parts 405, 411, 413 and 414; 2014. Available at: http:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2014-11-06\/pdf\/2014-26182.pdf . Accessed January 23, 2015."},{"key":"30_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ki.2010.167","volume":"78","author":"GA Block","year":"2010","unstructured":"Block GA, Zaun D, Smits G, Persky M, Brillhart S, Nieman K, et al. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int. 2010;78:578\u201389.","journal-title":"Kidney Int"},{"key":"30_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/00003088-200948050-00002","volume":"48","author":"D Padhi","year":"2009","unstructured":"Padhi D, Harris R. Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride. Clin Pharmacokinet. 2009;48:303\u201311.","journal-title":"Clin Pharmacokinet"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","volume":"13","author":"WG Goodman","year":"2002","unstructured":"Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, et al. The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol. 2002;13:1017\u201324.","journal-title":"J Am Soc Nephrol"},{"key":"30_CR13","volume-title":"Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. ed 2013","author":"U.S. Renal Data System","year":"2013","unstructured":"U.S. Renal Data System. USRDS 2013 Annual Data Report. In: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. ed 2013. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013."},{"key":"30_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1159\/000350213","volume":"37","author":"RD Kilpatrick","year":"2013","unstructured":"Kilpatrick RD, Newsome BB, Zaun D, Liu J, Solid CA, Nieman K, et al. Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients. Am J Nephrol. 2013;37:389\u201398.","journal-title":"Am J Nephrol"},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1542-4758.2009.00397.x","volume":"14","author":"Y Gincherman","year":"2010","unstructured":"Gincherman Y, Moloney K, McKee C, Coyne DW. Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients. Hemodial Int. 2010;14:68\u201372.","journal-title":"Hemodial Int"},{"key":"30_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2215\/CJN.09471209","volume":"5","author":"C Gardham","year":"2010","unstructured":"Gardham C, Stevens PE, Delaney MP, LeRoux M, Coleman A, Lamb EJ. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol. 2010;5:1261\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"30_CR17","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"GM Chertow","year":"2012","unstructured":"Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367:2482\u201394.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-015-0030-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0030-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0030-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T01:12:39Z","timestamp":1651626759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-015-0030-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,31]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1186\/s12882-015-0030-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,31]]},"assertion":[{"value":"26 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}